unlik
infect
agent
virus
encod
full
complement
protein
allow
prolifer
independ
host
consequ
life
cycl
virus
depend
upon
numer
host
protein
may
gener
term
host
cofactor
increas
understand
virus
coopt
host
cofactor
gener
maintain
permiss
environ
replic
highlight
target
antivir
intervent
substanti
bodi
evid
support
role
divers
viral
life
cycl
cyclophilin
famili
highli
conserv
peptidylprolyl
cistran
isomeras
peptid
bond
join
adjac
amino
acid
partial
doubl
bond
charact
restrict
free
rotat
bond
peptid
bond
two
energeticallypref
state
exist
tran
state
favor
due
steric
hindranc
ci
state
cross
state
energet
costli
xaapro
peptid
bond
howev
energi
minima
similar
ci
tran
isom
result
higher
percentag
isom
contain
ci
peptidylprolyl
bond
stereost
peptidylprolyl
bond
critic
mani
biolog
process
includ
signal
enzym
function
membran
traffick
spontan
interconvers
howev
occur
physiologicallyimpract
rate
ie
order
second
potenti
trap
prolinecontain
region
protein
particular
conform
novel
enzym
peptidylprolyl
cistran
isomeras
ppias
isol
catalyz
cistran
interconvers
use
target
peptid
sequenc
alaalaproph
chymotrypsincoupl
proteas
assay
peptid
major
peptidylprolyl
bond
tran
state
make
high
affin
substrat
proteas
minor
ci
isom
poor
substrat
cleav
rate
determin
spontan
isomer
prolin
rate
greatli
enhanc
ppias
addit
enzym
shown
involv
refold
ureadenatur
ribonucleas
cellular
protein
independ
concurr
effort
identifi
cellular
receptor
immunosuppress
cyclosporin
csa
led
discoveri
cytosol
protein
high
affin
csa
protein
term
cyclophilin
cyp
would
turn
protein
ppias
human
protein
kda
cyclophilin
hcypa
encod
gene
ppia
human
cypa
mediat
immunosuppress
function
csa
format
csacypa
complex
complex
bind
inhibit
function
protein
phosphatas
calcineurin
normal
function
dephosphoryl
nfat
transcript
factor
import
cell
activ
cyclophilin
gene
found
genom
domain
life
includ
mimiviru
cyclophilin
famili
larg
implic
variou
diseas
includ
cancer
diabet
neurodegener
atherosclerosi
tabl
defin
presenc
conserv
cyclophilinlik
domain
cld
mani
also
contain
addit
domain
may
function
independ
cld
furthermor
cld
exhibit
ppias
activ
test
vitro
suggest
even
singl
domain
cyclophilin
may
ppiaseindepend
role
protein
chaperon
quaternari
structur
regul
cyclophilin
protein
fkbp
also
exhibit
ppias
activ
anoth
immunosuppress
inhibit
lymphocyt
activ
use
clinic
facilit
transplant
graft
accept
togeth
cyclophilin
fkbp
compris
immunophilin
famili
name
bind
immunosuppress
agent
csa
rapamycin
least
thirteen
human
gene
encod
protein
contain
one
four
fkbp
domain
like
cyclophilin
fkbp
exhibit
divers
biolog
function
csacyp
complex
exert
immunosuppress
effect
ident
mechan
despit
distinct
structur
compound
protein
two
complex
nevertheless
possess
similar
composit
surfac
bind
calcineurin
inhibit
cell
activ
rapamycinfkbp
complex
hand
target
mammalian
target
rapamycin
mtor
pathway
inhibit
cell
prolifer
final
nonimmunophilin
class
ppias
parvulinlik
protein
also
describ
includ
two
human
gene
encod
least
three
distinct
protein
first
link
viral
replic
host
cyclophilin
report
two
decad
ago
luban
colleagu
identifi
cypa
cypb
interact
partner
gag
polyprotein
use
yeast
twohybrid
screen
subsequ
report
cypa
cypb
specif
incorpor
virion
via
specif
interact
residu
capsid
ca
activ
site
cypa
mutat
cypabind
site
ca
knockout
cypa
tcell
line
significantli
impair
replic
although
initi
hypothes
virionassoci
cypa
requir
life
cycl
later
studi
reveal
role
specif
cypa
present
target
rather
produc
cell
hiv
virion
produc
presenc
csa
cypaknockdown
cell
exhibit
defect
infect
permiss
cell
wildtyp
viru
produc
presenc
cypa
could
product
infect
cypadeplet
target
cell
mechan
cypa
function
facilit
hiv
infect
fulli
understood
may
relat
regul
stabil
incom
viral
capsid
addit
provir
factor
hivpermiss
human
cell
abil
cypa
bind
hiv
capsid
also
contribut
intrins
immun
mechan
underli
speciesspecif
restrict
hiv
infect
earli
attempt
establish
hiv
infect
nonhuman
primat
cell
line
reveal
domin
capsiddepend
block
postentri
immedi
prior
revers
transcript
old
world
monkey
protein
respons
restrict
identifi
rhesu
macaqu
bind
incom
viral
capsid
halt
infect
human
protein
weak
inhibitori
action
like
due
sequenc
diverg
ctermin
domain
mediat
recognit
capsid
involv
cypa
restrict
phenotyp
first
implic
result
csa
treatment
owl
monkey
cell
paradox
increas
hiv
infect
presum
counteract
restrict
factor
discoveri
trimcyp
fusion
gene
owl
monkey
offer
immedi
explan
observ
retrotranspos
cypa
domain
would
target
directli
incom
capsid
exert
antivir
activ
disrupt
cypaca
interact
csa
reliev
restrict
remark
exampl
converg
evolut
perhap
defens
pathogen
independ
retrotransposit
cypa
occur
sever
differ
primat
speci
result
least
three
distinct
trimcyp
fusion
chimer
protein
transcript
express
addit
variant
restrict
function
unfus
also
depend
cypa
case
cypa
may
modul
ca
structur
present
better
bind
surfac
recognit
regardless
mechan
oppos
role
cypa
permiss
nonpermiss
cell
converg
evolut
trimcyp
fusion
gene
multipl
way
use
cypa
gain
optim
access
viral
capsid
strongli
argu
highli
conserv
function
cypamedi
recognit
viral
capsid
coevolut
retrovirus
host
cell
final
role
cypa
hiv
pathogenesi
also
support
genomewid
associ
studi
show
singl
nucleotid
polymorph
snp
regulatori
region
cypa
gene
influenc
hiv
suscept
diseas
progress
like
modul
cypa
express
two
hiv
protein
vpr
also
report
interact
cypa
cypabind
site
vpr
first
map
prolinecontain
peptid
nterminu
fulllength
vpr
assay
interact
prolinefre
region
nearer
cterminu
identifi
site
higher
affin
cypa
first
propos
natur
bind
sequenc
cypa
relev
cypabind
vpr
function
hiv
life
cycl
ie
induc
cell
cycl
arrest
controversi
remain
determin
interact
observ
vitro
also
occur
infect
cell
anoth
cyclophilin
implic
lifecycl
also
name
larg
protein
contain
ctermin
cld
compon
nuclear
pore
complex
npc
hiv
reli
transport
replic
intermedi
identifi
two
genom
sirna
screen
host
factor
requir
hiv
infect
specif
nuclear
import
preintegr
complex
pic
recent
ca
shown
directli
bind
cld
interact
may
influenc
pic
import
well
integr
prefer
viral
genom
unlik
cypaca
interact
interact
insensit
csa
surprisingli
cypa
deplet
knockdown
cell
rescu
hiv
infect
support
role
two
cabind
cyclophilin
nuclear
import
pathway
result
consist
previou
studi
implic
cypa
nuclear
transport
inde
suggest
schaller
et
al
cldcontain
protein
may
act
regul
time
critic
event
case
author
propos
monomer
cypa
may
act
stabil
ca
reach
nuclear
pore
wherea
multipl
copi
present
npc
promot
uncoat
follow
report
direct
antihcv
effect
csa
hcv
replicon
system
essenti
role
cyclophilin
hcv
replic
support
correl
abil
differ
csa
deriv
bind
cyclophilin
inhibit
hcv
ident
specif
isoform
cyclophilin
import
hcv
replic
howev
initi
controversi
sever
independ
group
demonstr
cypa
univers
specif
requir
hcv
infect
perhap
surpris
consid
high
express
cypa
isoform
rel
member
cyp
famili
also
demonstr
ppias
motif
cypa
requir
function
hcv
cofactor
intriguingli
snp
ppia
gene
destabil
cypa
protect
hepatocyt
hcv
infect
cell
cultur
suggest
ppia
snp
contribut
observ
heterogen
hcv
permiss
hepatoma
cell
popul
vitro
precis
role
cypa
hcv
life
cycl
therefor
antivir
mechan
csa
deriv
still
fulli
understood
cypa
propos
stabil
hcv
replic
complex
bind
hcv
replicas
modul
rnabind
properti
nonstructur
protein
act
cofactor
rna
polymeras
influenc
process
hcv
polyprotein
cypa
may
also
play
role
one
step
hcv
infect
cycl
earli
csa
inhibit
studi
use
subgenom
replicon
assay
measur
rna
replic
step
entri
assembl
subsequ
observ
differ
cyclophilin
inhibitor
cpi
sensit
subgenom
replicon
fulllength
virus
suggest
function
cyclophilin
addit
step
viral
assembl
determin
specif
role
cypa
hcv
assembl
difficult
howev
due
fact
replic
prerequisit
assembl
natur
infect
cycl
overcom
obstacl
nag
et
al
devis
approach
normal
rna
replic
first
specif
examin
assembl
cypa
knockdown
cell
result
demonstr
cypa
inde
play
addit
role
assembl
step
hcv
life
cycl
recent
report
show
cypa
could
also
interact
interferon
ifn
regulatori
factor
vitro
howev
previou
studi
demonstr
csa
function
ifnindepend
mechan
signific
interact
remain
unclear
involv
cypa
action
first
implic
analysi
mutat
confer
csa
resist
hcv
replicon
vitro
later
confirm
demonstr
direct
interact
recombin
domain
ii
cypa
even
though
viral
protein
includ
also
suggest
target
cypa
interact
strongest
experiment
support
contrast
welldefin
ca
cypabind
site
multipl
prolin
residu
serv
put
substrat
cypa
ppias
activ
domain
ii
iii
elucid
structur
chang
induc
cypabind
isomer
next
logic
step
challeng
intrins
disord
natur
domain
despit
strong
inhibitori
effect
csa
vitro
vivo
effect
csa
hcv
infect
diseas
progress
less
clear
least
liver
transplant
patient
direct
comparison
patient
receiv
either
csa
tacrolimu
latter
antihcv
effect
vitro
fail
show
signific
differ
sever
recurr
hcv
studi
hand
combin
ifna
csa
effect
achiev
sustain
virolog
respons
ifna
monotherapi
especi
patient
genotyp
viru
high
viral
load
interestingli
clinic
trial
csa
deriv
lack
immunosuppress
function
shown
compound
potent
suppress
hcv
viral
load
patient
may
becom
part
futur
combin
therapi
hcv
sever
reason
could
account
differ
transplant
patient
result
posit
clinic
studi
first
immun
function
transplant
patient
suppress
csa
antivir
effect
alon
may
enough
suppress
viru
clinic
cpi
lack
immunosuppress
function
second
standard
dosag
csa
use
transplant
patient
low
far
antihcv
function
concern
lead
cpi
alisporivir
alreadi
potent
csa
inhibit
hcv
replic
vitro
given
least
twice
daili
dosag
frequent
csa
liver
transplant
patient
final
sequenc
polymorph
flank
conserv
region
may
affect
vivo
suscept
csa
develop
noncsaderiv
cpi
may
offer
structur
divers
class
hosttarget
compound
vitro
hcv
resist
cpi
report
various
recent
data
point
conserv
prolinerich
region
domain
ii
hotspot
develop
resist
mutat
mutat
affect
affin
cypa
may
instead
function
promot
conform
tendenc
natur
induc
cypa
bind
unlik
viral
resist
direct
antivir
agent
daa
magnitud
vitro
resist
cpi
rel
low
less
fold
oppos
thousand
fold
consist
genet
barrier
cpi
pose
clinic
studi
also
higher
daa
common
concern
target
host
protein
associ
cellular
toxic
howev
case
cypa
knockout
studi
human
cell
line
mice
suggest
cypa
dispens
basic
cell
surviv
potenti
role
cyclophilin
replic
influenza
viru
detail
separ
review
special
issu
yeast
cypa
homolog
inhibit
viral
replic
protein
tombusviru
interestingli
parvulin
ppias
could
also
inhibit
tombusviru
model
support
overlap
function
among
ppias
class
west
nile
viru
rna
nonstructur
protein
found
interact
directli
cypa
infect
cell
manner
although
csa
much
less
activ
inhibit
wnv
hcv
replic
pathogenesi
mani
human
virus
report
regul
either
csa
cyclophilin
includ
polyomaviru
bk
arteriviru
rotaviru
human
cytomegaloviru
vesicular
stomat
viru
vaccinia
viru
measl
viru
human
papillomaviru
coronavirus
hepat
b
viru
divers
potenti
function
host
cyclophilin
viral
life
cycl
evid
less
appar
conserv
role
exampl
whether
cyclophilinviru
interact
uniqu
particular
virus
part
larger
broad
theme
uncertain
furthermor
cellular
viral
substrat
cyclophilin
fulli
defin
implic
catalyt
alter
conform
fold
protein
cldcontain
protein
found
domain
life
even
found
within
genom
least
one
viru
mimiviru
highlight
conserv
critic
role
cyclophilin
like
play
host
cell
research
effort
toward
understand
role
cyclophilin
play
viral
life
cycl
normal
cell
physiolog
expand
understand
cell
whole
reveal
new
host
drug
target
